FN Archimer Export Format
PT J
TI Antimicrobial Resistance in Wildlife in Guadeloupe (French West Indies): Distribution of a Singlebla(CTX-M-1)/IncI1/ST3 Plasmid Among Humans and Wild Animals
BT 
AF GUYOMARD-RABENIRINA, Stephanie
   REYNAUD, Yann
   POT, Matthieu
   ALBINA, Emmanuel
   COUVIN, David
   DUCAT, Celia
   GRUEL, Gaelle
   FERDINAND, Severine
   LEGRENEUR, Pierre
   LE HELLO, Simon
   MALPOTE, Edith
   SADIKALAY, Syndia
   TALARMIN, Antoine
   BREUREC, Sebastien
AS 1:1;2:1;3:1;4:2,3;5:1;6:1;7:1;8:1;9:4;10:5,6;11:7;12:1;13:1;14:1,8,9;
FF 1:;2:;3:;4:;5:;6:;7:;8:;9:;10:;11:;12:;13:;14:;
C1 Inst Pasteur Guadeloupe, Transmiss Reservoir & Divers Pathogens Unit, Pointe A Pitre, Guadeloupe, France.
   CIRAD, UMR ASTRE, Montpellier, France.
   Univ Montpellier, CIRAD, INRA, UMR ASTRE, F-34398 Montpellier, France.
   Univ Claude Bernard Lyon 1, Univ Lyon, Interuniv Lab Human Movement Biol E4 7424, Villeurbanne, France.
   Inst Pasteur, Enter Bacterial Pathogens Unit, Paris, France.
   Univ Caen Normandy, EA2656, GRAM 2 0, UNICAEN,Grp Rech Adaptat Microbienne, Caen, France.
   Univ Hosp Guadeloupe, Lab Clin Microbiol, Pointe A Pitre, Guadeloupe, France.
   Univ Antilles, Fac Med Hyacinthe Bastaraud, Pointe A Pitre, Guadeloupe, France.
   Ctr Clin Invest 1424, INSERM, Pointe A Pitre, Guadeloupe, France.
C2 INST PASTEUR GUADELOUPE, FRANCE
   CIRAD, FRANCE
   UNIV MONTPELLIER, FRANCE
   UNIV LYON, FRANCE
   INST PASTEUR, FRANCE
   UNIV CAEN NORMANDIE, FRANCE
   UNIV HOSP GUADELOUPE, FRANCE
   UNIV ANTILLES, FRANCE
   INSERM, FRANCE
IN DOAJ
IF 3.941
TC 21
UR https://archimer.ifremer.fr/doc/00771/88293/93864.pdf
   https://archimer.ifremer.fr/doc/00771/88293/93865.tiff
   https://archimer.ifremer.fr/doc/00771/88293/93866.tiff
   https://archimer.ifremer.fr/doc/00771/88293/93867.jpeg
   https://archimer.ifremer.fr/doc/00771/88293/93868.docx
   https://archimer.ifremer.fr/doc/00771/88293/93869.xlsx
   https://archimer.ifremer.fr/doc/00771/88293/93870.xls
LA English
DT Article
DE ;Escherichia coli;wild animals;antimicrobial resistance;extended-spectrum beta-lactamase;plasmid
AB Limited data are available on the contribution of wildlife to the spread of antibacterial resistance. We determined the prevalence of resistance to antibiotics inEscherichia coliisolates collected from wild animals in 2013 and 2014 and the genetic basis for resistance to third-generation cephalosporin in Guadeloupe. We recovered 52 antibiotic-resistant (AR)E. colistrains from 48 of the 884 (5.4%) wild animals tested (46 iguanas, 181 birds, 289 anoles, and 368 rodents at 163 sampling sites). Rodents had higher rates of carriage (n= 38, 10.3%) than reptiles and birds (2.4% and 1.1%, respectively,p< 0.001). A significant association (p< 0.001) was found between the degree of anthropization and the frequency of ARE. colicarriage for all species. The carriage rate of ciprofloxacin- and cefotaxime-resistant isolates was 0.7% (6/884) and 1.5% (13/884), respectively. Most (65.4%) ARE. coliwere multi-drug resistant, and the prevalence of extended-spectrum beta-lactamase (ESBL)-producingE. coliwas low (n= 7, 0.8%) in all species. Eight ESBL-producingE. coliwere recovered, two genetically unrelated isolates being found in one bird. These isolates and 20 human invasive ESBLE. coliisolates collected in Guadeloupe during the same period were investigated by whole genome sequencing.bla(CTX-M-1)was the only ESBL gene shared by three animal classes (humans,n= 2; birds,n= 2; rodents,n= 2). Thebla(CTX-M-1)gene and most of the antimicrobial resistance genes were present in a large conjugative IncI1 plasmid that was highly similar (>99% nucleotide identity) to ESBL-carrying plasmids found in several countries in Europe and in Australia. Although the prevalence of ESBL-producingE. coliisolates was very low in wild animals, it is of concern that the well-conserved IncI1 plasmid-carryingbla(CTX-M-1)is widespread and occurs in variousE. colistrains from animals and humans.
PY 2020
PD JUN
SO Frontiers In Microbiology
SN 1664-302X
PU Frontiers Media Sa
VL 11
UT 000555814600001
DI 10.3389/fmicb.2020.01524
ID 88293
ER

EF